Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


A Ca2+-ATPase Regulates E-cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells.

Dang DK, Makena MR, Llongueras JP, Prasad H, Ko M, Bandral M, Rao R.

Mol Cancer Res. 2019 Aug;17(8):1735-1747. doi: 10.1158/1541-7786.MCR-19-0070. Epub 2019 May 10.


Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases.

Gatla HR, Muniraj N, Thevkar P, Yavvari S, Sukhavasi S, Makena MR.

Int J Mol Sci. 2019 Mar 5;20(5). pii: E1110. doi: 10.3390/ijms20051110. Review.


Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer.

Pramanik KC, Makena MR, Bhowmick K, Pandey MK.

Int J Mol Sci. 2018 Dec 5;19(12). pii: E3890. doi: 10.3390/ijms19123890. Review.


Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.

Makena MR, Ranjan A, Thirumala V, Reddy AP.

Biochim Biophys Acta Mol Basis Dis. 2018 Nov 24. pii: S0925-4439(18)30476-9. doi: 10.1016/j.bbadis.2018.11.015. [Epub ahead of print] Review.


Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.

Song MM, Makena MR, Hindle A, Koneru B, Nguyen TH, Verlekar DU, Cho H, Maurer BJ, Kang MH, Reynolds CP.

Anticancer Drugs. 2019 Feb;30(2):117-127. doi: 10.1097/CAD.0000000000000696.


Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.

Makena MR, Cho HE, Nguyen TH, Koneru B, Verlekar DU, Hindle A, Kang MH, Reynolds CP.

Pediatr Blood Cancer. 2018 Dec;65(12):e27447. doi: 10.1002/pbc.27447. Epub 2018 Sep 24.


Reactive Oxygen Species-Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies.

Makena MR, Koneru B, Nguyen TH, Kang MH, Reynolds CP.

Mol Cancer Ther. 2017 Apr;16(4):649-661. doi: 10.1158/1535-7163.MCT-16-0749. Epub 2017 Jan 23.


Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.

Krytska K, Ryles HT, Sano R, Raman P, Infarinato NR, Hansel TD, Makena MR, Song MM, Reynolds CP, Mossé YP.

Clin Cancer Res. 2016 Feb 15;22(4):948-60. doi: 10.1158/1078-0432.CCR-15-0379. Epub 2015 Oct 5.


Activity of MM-398, nanoliposomal irinotecan (nal-IRI), in Ewing's family tumor xenografts is associated with high exposure of tumor to drug and high SLFN11 expression.

Kang MH, Wang J, Makena MR, Lee JS, Paz N, Hall CP, Song MM, Calderon RI, Cruz RE, Hindle A, Ko W, Fitzgerald JB, Drummond DC, Triche TJ, Reynolds CP.

Clin Cancer Res. 2015 Mar 1;21(5):1139-50. doi: 10.1158/1078-0432.CCR-14-1882.

Supplemental Content

Loading ...
Support Center